[ 2 ] Hungin AP, Whorwell PJ, Tack J, et al. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects[J]. Aliment Pharmacol Ther, 2003, 17(5): 643-650.
[3]
[ 3 ] Zhou H, Yao M, Cheng GY, et al. Prevalence and associated factors of functional gastrointestinal disorders and bowel habits in Chinese adolescents: a school-based study[J]. J Pediatr Gastroenterol Nutr, 2011, 53(2): 168-173.
[ 5 ] Ersryd A, Posserud I, Abrahamsson H, et al. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome Ⅱ versus Rome Ⅲ[J]. Aliment Pharmaeol Ther, 2007, 26(6): 953-961.
[6]
[ 6 ] Sperber AD, Shvartzman P, Friger M, et al. A comparative reappraisal of the RomeⅡ and RomeⅢ diagnostic criteria:are we getting closer to the ‘true’ prevalence of irritable bowel syndrome [J]. Eur J Gastroenterol Hepatol, 2007(19): 441-447.
[ 8 ] Drossman DA. RomeⅢ: the functional gastrointestinal disorders[M]. 3rd ed. McLean: Degnon Associates Inc, 2006: 1-26.
[9]
[ 9 ] Zheng S, Fu W, Zhou J, et al. Prevalence and related factors of irritable bowel syndrome among middle-school students in areas affected by Wenchuan Earthquake: an epidemiological study[J]. J Clin Gastroenterol, 2012, 46(4): 345-346.
Engsbro AL, Simren M, Bytzer P. Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome Ⅲ classification[J]. Aliment Pharmacol Ther, 2012, 35(3): 350-359.
[17]
Yao X, Yang YS, Cui LH, et al. Subtypes of irritable bowel syndrome on RomeⅢ criteria : a multi-center study[J]. J Gastroenterol Hepatol, 2011, 27(4):760-765.
[18]
Ebling B, Jurci D, Gmajni R, et al. Anthropological, demographic and socioeconomic characteristics of irritable bowel syndrome[J]. Coll Antropol, 2011, 35(2): 513-521.
[19]
Drossman DA, Chang L, Bellamy N, et al. Severity in irritable bowel syndrome: a Rome Foundation Working Team report[J]. Am J Gastroenterol, 2011, 106(10): 1749-1759.